HYDROMORPHONE (a) 1MG/ML IN NS, 50ML, 75 ML, 100ML, 175ML(NDC 00703-0018-01 and NDC 00409-2634-5...

FDA Recall #D-0296-2023 — Class II — December 27, 2022

Recall #D-0296-2023 Date: December 27, 2022 Classification: Class II Status: Terminated

Product Description

HYDROMORPHONE (a) 1MG/ML IN NS, 50ML, 75 ML, 100ML, 175ML(NDC 00703-0018-01 and NDC 00409-2634-50) ; (b) 5MG/ML IN NS 60ML, 100ML, 250ML; pain, Rx only, used with a Curlin pump or no pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320, NDC# 00409-2634-50

Reason for Recall

Lack of sterility assurance

Recalling Firm

Sentara Infusion Services — Chesapeake, VA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

37 bags

Distribution

Dispensed to Patients Nationwide.

Code Information

Beyond Use Date: December 24-31, 2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated